Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications (Q36579595)
Jump to navigation
Jump to search
scientific article published on 13 December 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications |
scientific article published on 13 December 2012 |
Statements
1 reference
Pharmacological inhibition of nicotinamide phosphoribosyltransferase (NAMPT), an enzyme essential for NAD+ biosynthesis, in human cancer cells: metabolic basis and potential clinical implications (English)
1 reference
Bo Tan
1 reference
Debra A Young
1 reference
Zhao-Hai Lu
1 reference
Tao Wang
1 reference
Timothy I Meier
1 reference
Robert L Shepard
1 reference
Kenneth Roth
1 reference
Yan Zhai
1 reference
Karen Huss
1 reference
Ming-Shang Kuo
1 reference
James Gillig
1 reference
Saravanan Parthasarathy
1 reference
Timothy P Burkholder
1 reference
Michele C Smith
1 reference
Sandaruwan Geeganage
1 reference
Genshi Zhao
1 reference
1 reference
Identifiers
1 reference